Saegis Pharmaceuticals' Series C Round

Saegis Pharmaceuticals raised a round of funding on June 06, 2005. Investors include Lumira Ventures.

Saegis Pharmaceuticals is a leader in the development of next generation medicines to improve memory and cognition deficits associated with human Central Nervous System (CNS) diseases. As the first co…

Articles about Saegis Pharmaceuticals' Series C Round: